Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Total number of subjects required for comparative efficacy RCTs between anti-TNF agents for CD induction and maintenance of remission
| Total subject number (induction/maintenance) | Infliximab | Certolizumab pegol | Adalimumab |
|---|---|---|---|
| Infliximab | – | 3272/558 | 4780/3076 |
| Certolizumab pegol | 3272/558 | – | 104518/286 |
| Adalimumab | 4780/3076 | 104518/286 | – |
